Lipoprotein glomerulopathy (LPG) is a rare autosomal recessive glomerulopathy associated with the deposition of lipoprotein thrombi in the capillary lumina due to apoE gene mutations. Abnormal plasma lipoprotein profile and marked increase in serum apoliprotein E (apoE) are characteristic clinical data. The compromised patients can present nephrotic syndrome, hematuria, and progressive renal failure. Herein, the authors present the first described case of LPG in a Brazilian male patient, 11 years, who presented with a steroid-resistant nephrotic syndrome. Renal function was normal. Kidney biopsy showed markedly enlarged glomerulus, with dilated capillary loops and weak eosinophilic lipoprotein thrombi in the capillary lumina. Interstitium, tubules, arteries, and veins showed normal histologic aspect. Genotypic study for the apoE gene showed the presence of the alleles E3 and E4. The diagnosis of LPG was then performed. The patient received lipid-lowering treatment. After 2 years of follow-up, renal function is gradually decreasing, with persisting heavy proteinuria, despite a marked decrease in serum cholesterol and triglycerides levels.

Download full-text PDF

Source
http://dx.doi.org/10.5935/0101-2800.20140015DOI Listing

Publication Analysis

Top Keywords

lipoprotein glomerulopathy
8
lipoprotein thrombi
8
thrombi capillary
8
capillary lumina
8
apoe gene
8
nephrotic syndrome
8
renal function
8
lipoprotein
5
glomerulopathy case
4
case report
4

Similar Publications

First patient diagnosed with lipoprotein glomerulopathy and Alport syndrome.

Nephrology (Carlton)

December 2024

Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China.

Article Synopsis
  • - Alport syndrome (AS) is a common genetic kidney disorder resulting from mutations in COL4A3, COL4A4, and COL4A5 genes, leading to abnormal collagen IV structure and function.
  • - Lipoprotein glomerulopathy (LPG) is another inherited condition linked to mutations in the APOE gene, affecting lipid metabolism.
  • - A case is reported of an 11-year-old girl with both AS and LPG, exhibiting various symptoms and laboratory findings, and genetic tests identified specific pathogenic variants; the study highlights the need for early renal biopsy and whole-exome sequencing for accurate diagnosis.
View Article and Find Full Text PDF

A 33-year-old Japanese man was admitted for possible kidney disease because of massive proteinuria. Laboratory findings were characterized by marked urinary protein of 4.7 g/day and high-serum triglyceride levels of 266 mg/dL.

View Article and Find Full Text PDF

Background: Lipoprotein glomerulopathy (LPG) is a apolipoprotein E (ApoE)-related glomerular disease and has been associated with type III hyperlipidemia. Without appropriate treatment, chronic kidney disease (CKD) caused by LPG progresses, and approximately half of the patients develop end-stage kidney disease within 1-27 years of disease onset. However, few studies have highlighted the clinical course of cardiovascular diseases (CVDs) in patients with LPG.

View Article and Find Full Text PDF
Article Synopsis
  • * Eleven patients were analyzed, revealing a high incidence of proteinuria, dyslipidemia, and specific kidney changes observed through biopsies, with most showing mutations in the apolipoprotein E gene.
  • * The findings emphasize the importance of kidney biopsies for diagnosis and suggest that treatment with ACEIs or ARBs can help manage the disease progression in LPG patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!